Bambusa Therapeutics is a startup.
Bambusa Therapeutics is a startup.
Bambusa Therapeutics develops long-lasting bispecific antibodies for immune and inflammatory disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.